• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女孩多囊卵巢综合征的发病年龄可能比之前认为的更早。

Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought.

作者信息

Bronstein Jason, Tawdekar Sonali, Liu Yinghua, Pawelczak Melissa, David Raphael, Shah Bina

机构信息

Department of Pediatrics, New York University School of Medicine, New York, NY, USA.

出版信息

J Pediatr Adolesc Gynecol. 2011 Feb;24(1):15-20. doi: 10.1016/j.jpag.2010.06.003.

DOI:10.1016/j.jpag.2010.06.003
PMID:21262477
Abstract

OBJECTIVES

To study the age at diagnosis of polycystic ovarian syndrome (PCOS) in a pediatric population. To compare risk factors involved in causing PCOS in preadolescent and adolescent girls. To review the current literature on the reported age of PCOS in girls.

DESIGN

A retrospective chart review and systematic review of the literature.

PARTICIPANTS

Patients included 58 girls (age ≤ 18 yrs) with a diagnosis of PCOS based on the Rotterdam criteria. Girls were grouped as preadolescents (<13 yrs) or adolescents (13-18 yrs). Clinical and biochemical data were reviewed from the time of diagnosis.

MAIN OUTCOME MEASURES

Age at diagnosis. Differences in risk factors for PCOS (Ethnicity, obesity, family history of PCOS, birth weight, age at pubarche, thelarche and menarche, evidence of hyperandrogenism and/or insulin resistance) were compared between the two groups.

RESULTS

There were 26% (15/58) preadolescent girls (9-12 yrs) vs 74% (43/58) adolescents (13-18 yrs). There was no significant difference between the two groups in ethnicity, BMI z-score, family history of maternal PCOS, birth weight, hyperandrogenism, or insulin resistance. Preadolescents with PCOS had significantly earlier onset of pubarche and thelarche than adolescents with PCOS, by 1.9 and 1.5 yrs, respectively (P = 0.018, 0.030). In addition to earlier puberty, PCOS developed 2.1 years sooner after thelarche in preadolescents than in adolescents. (P = 0.008) Preadolescents were significantly taller for age than adolescents (72nd % vs 43rd %) (P = 0.005). A review of the 28 studies published in the last 3 years that included PCOS patients with age <=18 yrs described only 6.4% (27/425) of pediatric subjects with age <13 yrs. Four were primarily pediatric studies that included patients under the age of 13 yrs, with 9.4% (12/127) of the patients <13 yrs.

CONCLUSION

Increased awareness of PCOS in young females is needed. PCOS may occur at a younger age in girls who develop early pubarche and thelarche. Therefore, the diagnosis and workup should be considered in young girls with risk factors suggestive of PCOS.

摘要

目的

研究儿科人群中多囊卵巢综合征(PCOS)的诊断年龄。比较青春期前和青春期女孩患PCOS的相关危险因素。综述目前关于女孩PCOS报道年龄的文献。

设计

回顾性病历审查和文献系统综述。

参与者

纳入58名诊断为PCOS的女孩(年龄≤18岁),诊断依据鹿特丹标准。女孩分为青春期前(<13岁)或青春期(13 - 18岁)。从诊断时起回顾临床和生化数据。

主要观察指标

诊断年龄。比较两组PCOS危险因素(种族、肥胖、PCOS家族史、出生体重、阴毛初现年龄、乳房初现年龄和月经初潮年龄、高雄激素血症和/或胰岛素抵抗证据)的差异。

结果

青春期前女孩占26%(15/58)(9 - 12岁),青春期女孩占74%(43/58)(13 - 18岁)。两组在种族、BMI z评分、母亲PCOS家族史、出生体重、高雄激素血症或胰岛素抵抗方面无显著差异。患有PCOS的青春期前女孩阴毛初现和乳房初现的起始时间分别比患有PCOS的青春期女孩早1.9年和1.5年(P = 0.018,0.030)。除青春期提前外,青春期前女孩在乳房初现后比青春期女孩早2.1年患PCOS(P = 0.008)。青春期前女孩的年龄别身高显著高于青春期女孩(第72百分位数 vs 第43百分位数)(P = 0.005)。对过去3年发表的28项研究进行综述,这些研究纳入了年龄≤18岁的PCOS患者,其中年龄<13岁的儿科受试者仅占6.4%(27/425)。四项主要是儿科研究纳入了13岁以下的患者,其中9.4%(12/127)的患者<13岁。

结论

需要提高对年轻女性PCOS 的认识。PCOS可能在阴毛初现和乳房初现较早的女孩中发病年龄更小。因此,对于有提示PCOS危险因素的年轻女孩应考虑进行诊断和检查。

相似文献

1
Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought.女孩多囊卵巢综合征的发病年龄可能比之前认为的更早。
J Pediatr Adolesc Gynecol. 2011 Feb;24(1):15-20. doi: 10.1016/j.jpag.2010.06.003.
2
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.多囊卵巢综合征女性的卵巢手术以缓解症状
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2.
3
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中中度和重度抑郁及焦虑症状的高患病率:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044.
4
Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles.青少年多囊卵巢综合征与长期代谢风险:从甘油三酯与高密度脂蛋白胆固醇比值及高密度脂蛋白胆固醇谱获得的见解
Front Endocrinol (Lausanne). 2025 Jun 3;16:1579217. doi: 10.3389/fendo.2025.1579217. eCollection 2025.
5
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
6
Gonadotropins for ovulation induction in women with polycystic ovary syndrome.用于多囊卵巢综合征女性促排卵的促性腺激素。
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD010290. doi: 10.1002/14651858.CD010290.pub4.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.评估血清抗苗勒管激素作为巴基斯坦女性多囊卵巢综合征诊断生物标志物的作用。
Int J Gynaecol Obstet. 2025 Jun 25. doi: 10.1002/ijgo.70240.
9
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
10
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.腹腔镜下使用透热法或激光打孔以诱导无排卵性多囊卵巢综合征患者排卵。
Cochrane Database Syst Rev. 2012 Jun 13(6):CD001122. doi: 10.1002/14651858.CD001122.pub4.

引用本文的文献

1
Thyroid Disorders in Patients with Polycystic Ovarian Syndrome in a Tertiary Care Center: An Observational study.三级医疗中心多囊卵巢综合征患者的甲状腺疾病:一项观察性研究。
JNMA J Nepal Med Assoc. 2024 Dec;62(280):819-822. doi: 10.31729/jnma.8833. Epub 2024 Dec 31.
2
Evolving global trends in PCOS burden: a three-decade analysis (1990-2021) with projections to 2036 among adolescents and young adults.多囊卵巢综合征负担的全球趋势演变:一项为期三十年(1990 - 2021年)的分析,并对青少年和青年至2036年进行预测。
Front Endocrinol (Lausanne). 2025 May 12;16:1569694. doi: 10.3389/fendo.2025.1569694. eCollection 2025.
3
A Global Survey of Ethnic Indian Women Living with Polycystic Ovary Syndrome: Co-Morbidities, Concerns, Diagnosis Experiences, Quality of Life, and Use of Treatment Methods.
全球多囊卵巢综合征印度裔女性生活状况调查:合并症、关注点、诊断体验、生活质量和治疗方法的使用情况。
Int J Environ Res Public Health. 2022 Nov 28;19(23):15850. doi: 10.3390/ijerph192315850.
4
A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).多囊卵巢综合征(PCOS)的病因、遗传学和免疫学简述。
J Assist Reprod Genet. 2022 Nov;39(11):2439-2473. doi: 10.1007/s10815-022-02625-7. Epub 2022 Oct 3.
5
Current situation of menstruation and gynecological diseases prevalence among Chinese women: a cross-sectional study.中国女性月经和妇科疾病流行现状:一项横断面研究。
BMC Womens Health. 2022 Jul 4;22(1):270. doi: 10.1186/s12905-022-01860-5.
6
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification.解构综合征:多囊卵巢综合征发病机制和分类的基因组学见解。
Endocr Rev. 2022 Nov 25;43(6):927-965. doi: 10.1210/endrev/bnac001.
7
Outcomes of a Mindfulness-Based Healthy Lifestyle Intervention for Adolescents and Young Adults with Polycystic Ovary Syndrome.基于正念的健康生活方式干预对多囊卵巢综合征青少年及年轻患者的影响
J Pediatr Adolesc Gynecol. 2022 Jun;35(3):305-313. doi: 10.1016/j.jpag.2021.10.016. Epub 2021 Nov 4.
8
Polycystic Ovarian Syndrome roots needs to be rooted out at the outset: Will early screening help?多囊卵巢综合征根源需从一开始就根除:早期筛查会有帮助吗?
Pak J Med Sci. 2021 Sep-Oct;37(5):1254-1255. doi: 10.12669/pjms.37.5.4509.
9
Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists.妇产科医生在使用胰高血糖素样肽-1 受体激动剂治疗肥胖症患者中的策略。
J Womens Health (Larchmt). 2021 Jul;30(7):1016-1027. doi: 10.1089/jwh.2020.8683. Epub 2021 Feb 24.
10
Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome.多囊卵巢综合征雄激素诱导大鼠模型中卵巢线粒体动力学和细胞命运调控。
Sci Rep. 2020 Jan 23;10(1):1021. doi: 10.1038/s41598-020-57672-w.